Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

384 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Completed

Registry on Hypomethylating Agents in Myeloid Neoplasms

NCT01595295

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • LKH Feldkirch, Innere Med. II, Interne E Feldkirch, Austria
  • LKH Fürstenfeld Fürstenfeld, Austria
  • UK Graz: Universitätsklinik für Innere Medizin; Klinische Abteilung für Hämatologie Graz, Austria
  • Universitätsklinik für Innere Medizin V Innsbruck, Austria
View all 20 locations
View Trial Details
Completed

Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant

NCT01812252

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Kaiser Permanente Washington Seattle, Washington, United States
View Trial Details
Completed

A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

NCT02367456

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • University of Alabama at Birmingham the Kirklin Clinic Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Smilow Cancer Center at Yale New Haven Hospital New Haven, Connecticut, United States
View all 33 locations
View Trial Details
Completed

Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML

NCT04842604

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • Landeskrankenhaus Salzburg, Universitatsklinik fur Innere Medizin III der PMU Salzburg, Austria
  • Uniklinikum Salzburg, Landeskrankenhaus Salzburg Salzburg, Austria
  • Health Sciences Centre Winnipeg, Manitoba, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 18 locations
View Trial Details
Completed

5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS)

NCT01404741

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +13 more
Locations
  • Charité Campus Benjamin Franklin Berlin, Germany
  • Uniklinikum Bonn Bonn, Germany
  • Universität zu Köln Cologne, Germany
  • Universitätsklinikum Dresden Dresden, Germany
View all 17 locations
View Trial Details

Related conditions